Landon Grange, MD
Ophthalmology · Boise, IDNPI 1043620255
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,149 of the $5,376 with a category attached, or 77.2%. 15 manufacturers reported payments, led by Alcon at 34.0% of the total. 2025 is the largest year on record at $2,573, 5.0 times the $515 reported in 2019. Among ophthalmology clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $53.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Carl Zeiss Meditec USA, Inc.$2K
- Sight Sciences, Inc.$1K
- Rxsight Inc$272
- Kala Pharmaceuticals, Inc.$151
- Shire North American Group Inc$118
- plus $412 from 9 others
What the payments were for
- Travel & lodging$1,22723%
- Food & beverage$4,14977%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 45 | $1,828 |
| Carl Zeiss Meditec USA, Inc. | 7 | $1,535 |
| Sight Sciences, Inc. | 25 | $1,060 |
| Rxsight Inc | 4 | $272 |
| Kala Pharmaceuticals, Inc. | 3 | $151 |
| Shire North American Group Inc | 1 | $118 |
| AbbVie(2 entities) | 4 | $86 |
| Glaukos Corporation | 1 | $73 |
| Novartis | 3 | $67 |
| Amgen | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Nova Eye, Inc. | 1 | $37 |
| Bausch & Lomb Americas Inc. | 1 | $23 |
| Oyster Point Pharma, Inc. | 1 | $23 |
| Lensar, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,376 in reported general payments places this provider in the 95th percentile of 60 ophthalmology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 398 | $7,919 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 41 | $2,579 |
| Latanoprost | 13 | $117 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Boise
- Adam ReynoldsBoise$47K
- Ryan BarrettBoise$7K
- Jacob MongBoise$5K
- Ali Torab ParhizBoise$5K
- Gregory KentBoise$4K
- Mark HollingsheadBoise$3K
- Matthew NealeBoise$3K
- Denise CappsBoise$2K
- Scott LarsonBoise$2K
- Mark BoernerBoise$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.